Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event

Biochemical Journal

Volumn 377, Issue 1, 2004, Pages 249-255

  Cole, Adam ^a   Frame, Sheelagh ^b   Cohen, Philip ^a,b  

^a MRC Protein Phosphorylation Unit   (United Kingdom)

^b State Key Laboratory of Plant Physiology and Biochemistry   (United Kingdom)

Author keywords

Glycogen synthase kinase 3 (GSK3); Indirubin; Kenpaullone; Phosphotyrosine; Tyrosine kinase

Indexed keywords

BIOCHEMISTRY; CATALYST ACTIVITY; CELLS; ENZYME INHIBITION; ESCHERICHIA COLI; MUTAGENESIS;

PHOSPHORYLATION;

ENZYME KINETICS;

GENISTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; KENPAULLONE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYROSINE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CATALYSIS; CATALYST; CONTROLLED STUDY; DILUTION; ESCHERICHIA COLI; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MAMMAL CELL; MOLECULAR INTERACTION; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WILD TYPE;

CELL LINE; ENZYME INHIBITORS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MUTATION; NERVE GROWTH FACTOR; PHOSPHORYLATION; STAUROSPORINE; TYROSINE;

ANIMALIA; ESCHERICHIA COLI; INSECTA; MAMMALIA;

EID: 1642494586     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20031259     Document Type: Article

References (18)

1. Cohen, P. and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776
2. Frame, S. and Cohen, P. (2001) GSK3 takes centre stage more than 20 years after Its discovery. Biochem. J. 359, 1-16
3. Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F. and Woodgett, J. R. (1993) Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808
4. Wang, Q. M., Fiol, C. J., DePaoli-Roach, A. A. and Roach, P. J. (1994) Glycogen synthase kinase-3β is a dual specificity kinase differentially regulated by tyrosine and serine/ threonine phosphorylation. J. Biol. Chem. 269, 14566-14574
5. Kim, L., Liu, J. and Kimmel, A. R. (1999) The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification. Cell 99, 399-408
6. Lesort, M., Jope, R. S. and Johnson, G. V. (1999) Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase. J. Neurochem. 72, 576-584
7. Hartigan, J. A., Xiong, W. C. and Johnson, G. V. (2001) Glycogen synthase kinase 3β is tyrosine phosphorylated by PYK2. Biochem. Biophys. Res. Commun. 284, 485-489
8. Frame, S., Cohen, P. and Biondi, R. M. (2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7, 1321-1327
9. Leost, M., Schultz, C., Link, A., Wu, Y.-Z., Biernat, J., Mandelkow, E.-M., Bibb, J. A., Snyder, G. L., Greengard, P., Zaharevitz, O. W. et al. (2000) Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25. Eur. J. Biochem. 267, 5983-5994
10. Leclerc, S., Gamier, M., Hoessel, R., Marko, D., Bibb, J. A., Snyder, G. L., Greengard, P., Biernat, J., Wu, Y.-Z., Mandelkow, E.-M. et al. (2001) Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease: a property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276, 251-260
11. Bain, J., McLaughlan, H., Elliott, M. and Cohen, P. (2003) The specificities of protein kinase inhibitors: an update. Biochem. J. 371, 199-204
12. Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A. and Connelly, P. A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: study of Lck-and FynT-dependent cell activation. J. Biol. Chem. 271, 695-701
13. Dowler, S., Montalvo, L., Cantrell, D., Morrice, N. and Alessi, D. R. (2000) Phosphoinositide 3-kinase-dependent phosphorylation of the dual adaptor for phosphotyrosine and 3-phosphoinositides by the Src family of tyrosine kinase. Biochem. J. 349, 605-610
14. Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W. and Lee, C. M. (2000) Regulation and localisation of tyrosine 216 phosphorylation of GSK3β in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 97, 11074-11079
15. Murai, H., Okazaki, M. and Kikuchi, A. (1996) Tyrosine dephosphorylation of glycogen synthase kinase-3 is involved in its extracellular signal-dependent inactivation. FEBS Lett. 392, 153-160
16. Shaw, M., Cohen, P. and Alessi, D. R. (1997) Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett. 416, 307-311
17. Alessi, D. R., Andjelkovic, M., Caudwell, F. B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B. A. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541-6551
18. Stokoe, D., Campbell, D. G., Nakielny, S., Hidaka, H., Leevers, S. J., Marshall, C. and Cohen, P. (1992) MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 11, 3985-3994